Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1-Acetyl-N-(3-(4-(4-carbamoylbenzyl)piperidin-1-yl)propyl)-N-(3-chloro-4-methylphenyl)piperidine-4-carboxamide REF: 3D-INA99400CAS: 333994-00-6 | Min. 95% | To inquire | Tue 21 Jan 25 | |
TAK-220 REF: TM-T16973CAS: 333994-00-6 | 98% | To inquire | Mon 27 Jan 25 |
1-Acetyl-N-(3-(4-(4-carbamoylbenzyl)piperidin-1-yl)propyl)-N-(3-chloro-4-methylphenyl)piperidine-4-carboxamide
CAS:333994-00-6
Please enquire for more information about 1-Acetyl-N-(3-(4-(4-carbamoylbenzyl)piperidin-1-yl)propyl)-N-(3-chloro-4-methylphenyl)piperidine-4-carboxamide including the price, delivery time and more detailed …
Formula:
C31H41ClN4O3
Purity:
Min. 95%
Molecular weight:
553.14 g/mol
Ref: 3D-INA99400
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
TAK-220
CAS:333994-00-6
TAK-220: Oral CCR5 antagonist. IC50: 3.5 nM (RANTES), 1.4 nM (MIP-1α).
Formula:
C31H41ClN4O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
553.14
Ref: TM-T16973
5mg | 325.00 € | ||
25mg | 1,058.00 € | ||
50mg | 1,384.00 € | ||
100mg | 1,849.00 € | ||
1mL*10mM (DMSO) | 361.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025